Sort
39,280 grants matching “leukemia”
A novel miR-198 replacement therapy for pancreatic cancer
$473,915Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2017 · CA
A novel miR-198 replacement therapy for pancreatic cancer
$473,915Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2016 · CA
A novel miR-198 replacement therapy for pancreatic cancer
$473,915Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2018 · CA
Genetic Dissection of Drosophila Hematopoiesis
$473,878Utpal Banerjee · University Of California Los Angeles · R01 · FY2019 · HL
In Vivo Detection And Mechanisms of Regulatory B cell Function in Transplantation
$473,869David M Rothstein · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
$473,834A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2019 · HL
In Vivo Incorporation of Unnatural Amino Acids
$473,750Peter G Schultz · Scripps Research Institute, The · R01 · FY2016 · GM
In Vivo Incorporation of Unnatural Amino Acids
$473,750Peter G Schultz · Scripps Research Institute, The · R01 · FY2015 · GM
In Vivo Incorporation of Unnatural Amino Acids
$473,750Peter G Schultz · Scripps Research Institute, The · R01 · FY2014 · GM
Prevent IgM MGUS Progression by Targeting the Driver Mutation
$473,744Xinfang Yu · Baylor College Of Medicine · U54 · FY2024 · CA
Sickle Cell Anemia Mice Carrying Chromosomes from Four Human Haplotypes
$473,679Yuet W Kan · Children'S Hospital & Res Ctr At Oakland · U54 · FY2007 · HL
PROTEIN SIGNATURES OF LEUKEMIC CELLS
$473,630University Of California San Francisco · R33 · FY2002 · CA
A Model System for Physiological Exocytosis
$473,580Fredric S Cohen · Rush University Medical Center · R01 · FY2009 · GM
MECHANISMS OF MURINE TUMOR ERADICATION BY IMMUNOTHERAPY
$473,539University Of Washington · R37 · FY2003 · CA
The role of innate immunity in downregulation of the airway antioxidant response during paramyxovirus infection
$473,500Antonella Casola · University Of Texas Med Br Galveston · P01 · FY2018 · AI
Glucocorticoids in Lymphoblastic Leukemia
$473,354Mary V. Relling · St. Jude Children'S Research Hospital · R01 · FY2019 · CA
Induction of Tolerance to FVIII in Hemophilia
$473,337David William Scott · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2017 · HL
Mouse models of severe combined immunodeficiencies
$473,302Frederick W Alt · Beth Israel Deaconess Medical Center · P01 · FY2013 · AI
O-Glycosylation of Epidermal Growth Factor-like Motifs
$473,302Robert S. Haltiwanger · University Of Georgia · R01 · FY2021 · GM
Targeting PML for leukemia therapy.
$473,271Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA
Developing a novel therapeutic strategy for overcoming TKI resistance in ALL
$473,211Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · CA
ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIA
$473,190Alex Kentsis · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Transcriptional regulatory landscapes underlying FEZ Formation
$473,174Ralph S Marcucio · University Of California, San Francisco · R01 · FY2022 · DE
Determining the Origins and Vulnerabilities of Pediatric Treatment-Induced Gliomas
$473,097Adam Lyon Green · University Of Colorado Denver · R01 · FY2025 · NS
The function of MS4A3 in normal and malignant hematopoiesis
$473,053Michael W Deininger · Versiti Blood Health, Inc. · R01 · FY2025 · CA